研究者
J-GLOBAL ID：202301002305923312
更新日: 2024年07月20日
青木 マリア
アオキ マリア | Aoki Maria
所属機関・部署：
職名：
臨床研究医
論文 (8件)：
-
Toshiki Etani, Chiharu Wachino, Takuya Sakata, Maria Aoki, Masakazu Gonda, Nobuhiko Shimizu, Takashi Nagai, Rei Unno, Kazumi Taguchi, Taku Naiki, et al. Using fosfomycin to prevent infection following ureterorenoscopy in response to shortage of cephalosporins: a retrospective preliminary study. BMC urology. 2024. 24. 1. 145-145
-
Teruki Isobe, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Maria Aoki, et al. Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma. Oncology. 2024
-
Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Teruki Isobe, Yusuke Noda, Nobuhiko Shimizu, et al. C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study. Cancers. 2024. 16. 9
-
Teruki Isobe, Noriyasu Kawai, Maria Aoki, Toshiharu Morikawa, Masakazu Gonda, Nami Tomiyama, Takashi Nagai, Keitaro Iida, Toshiki Etani, Taku Naiki, et al. Late relapsing testicle cancer identified with isochromosome 12p (i12p) fluorescence in situ hybridization (FISH) analysis. Pathology international. 2024
-
Keitaro Iida, Taku Naiki, Toshiki Etani, Takashi Nagai, Yosuke Sugiyama, Teruki Isobe, Maria Aoki, Satoshi Nozaki, Yusuke Noda, Nobuhiko Shimizu, et al. Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma. Scientific reports. 2024. 14. 1. 2520-2520
もっと見る
講演・口頭発表等 (1件)：
-
Maintenance of skeletal muscles when receiving neoadjuvant chemotherapy improves the prognosis for patients with muscle invasive bladder cancer
(American Urological Association's 2023 Annual Meeting 2023)
学歴 (2件)：
- 2023 - 現在 名古屋市立大学 大学院医学研究科
- 2012 - 2018 徳島大学 医学部 医学科
前のページに戻る
